The health impacts of men losing their Y chromosome from their cells are increasingly coming to light, with the loss playing ...

Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now ...

Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 ...

ImPact Biotech is an advanced clinical-stage oncology company focused on the development and commercialization of Padeliporfin Vascular Targeted Photodynamic (VTP) therapy, a minimally invasive ...

Using AI and big data, Weizmann Institute researchers build MiTEs, or natural killer/T-cell Enhancers, to combat cancers, 5 ...

Immunotherapy, which harnesses our body's own immune system to fight cancer, has revolutionized modern oncology. Yet despite ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine franchise from three to up to six approved products b ...

Burning Rock Biotech Limited (NASDAQ: BNR, the 'Company” or 'Burning Rock”), a company focused on the application of next ...

AVJ16 – has blocked the cancer-driving RNA-binding protein IGF2BP1 in preclinical lung cancer models, curbing tumour growth while sparing healthy tissue, in ...

Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small ...